Clinical and morphological case of developing liver cirrhosis associated with viral hepatitis in a young patient

Cover Page

Cite item


The significance of chronic hepatitis is determined not only by the disease per se, but also by the increased risk of the formation of long-term adverse effects such as liver cirrhosis. Viral cirrhosis of the liver (as the outcome of chronic hepatitis B, C, B + D) comprise from 10% to 24.5% of all liver cirrhosis cases. Cirrhosis of the liver is considered as an irreversible stage of chronic hepatitis, more often observed in men above 40 years, but recently more and more its cases are found in young, working ones leading to disability. Due to the high liver regenerative potential, a prognosis for liver lesions of different etiologies may be rather favorable. As a result, early diagnostics, dynamic monitoring and the use of promising methods for treating liver pathology to stimulate its regeneration that compensates for lost liver functions are necessary. In the clinical and morphological case, pathomorphological changes in organs with liver cirrhosis, which developed as a result of viral hepatitis are described. The aim of the study was to describe pathomorphological changes in organs during liver cirrhosis, which developed due to viral hepatitis, which led to multiple organ failure in a young patient. Materials and methods. The analysis of the obtained accompanying medical documentation (outpatient card, medical history) was performed. The standard methodology of autopsy was used. To process histological sections of autopsy material, hematoxylin-eosin staining was used. Results. Histological examination in the liver shows development of portal tract fibrosis with lymphohistio cytic infiltration, formation of monolobular regenerated nodes, signs of edema, areas of demyelination, dystrophic changes in neurocytes, signs of acute renal failure, a combined profound change in the kidneys detected in the lungs and brain, which resulted in multiple organ failure and subsequent lethal outcome in a young patient. The early formation of portal hypertension with liver cirrhosis, esophageal and gastric varicose veins dilatation lead to fatal bleeding in half of patients. Therefore, timely diagnosed cirrhosis and hepatitis as their predecessors is one of the most relevant issues in medicine.

About the authors

O. V. Vorobeva

I.N. Ulianov Chuvash State University

Author for correspondence.
ORCID iD: 0000-0003-3259-3691

Olga V. Vorobeva,  PhD (Medicine), Associate Professor, Department of General and Clinical Morphology and Forensic Medicine 

428015, Cheboksary, Moskovskii pr., 15

Phone: +7 927 858-05-18 (mobile) 

Russian Federation

A. V. Lastochkin

I.N. Ulianov Chuvash State University; Republican Bureau of Forensic Medical Examination of the Ministry of Health of Chuvashia

ORCID iD: 0000-0001-5681-0246

Senior Lecturer, Department of General and Clinical Morphology and Forensic Medicine; Pathologist


Russian Federation


  1. Карев В.Е., Лобзин Ю.В., Цинзерлинг В.А. Сравни тельная характеристика клинического течения, повреждения и регенерации печени при хронической HBV- и HCV-инфекции // Журнал инфектологии. 2013. Т. 1, № 5. С. 91–98. [Karev V.E., Lobzin Yu.V., Cinserling V.A. The comparative description of clinical course, injury an regeneration of liver while chronic HBV- and HCV-infections course. Zhurnal infektologii = Journal Infectology, 2013, vol. 1, no. 5, pp. 91–98. (In Russ.)] doi: 10.22625/2072-6732-2013-5-1-91-98
  2. Могилевец Э.В., Горелик П.В., Батвинков Н.И. Методы стимуляции регенерации при циррозе печени // Новости хирургии. 2013. Т. 21, № 3. С. 103–109. [Mogilevec Je.V., Gorelik P.V., Batvinkov N.I. Methods of liver regeneration stimulation at liver cirrhosis. Novosti khirurgii = Surgery News, 2013, vol. 21, no. 3, рр. 103–109. (In Russ.)]
  3. Хронический вирусный гепатит С и цирроз печени: руководство для врачей. Под ред. А.Г. Рахмановой. СПб.: СпецЛит, 2016. 379 с. [Chronic viral hepatitis C and liver cirrhosis: a guide for doctors. Ed. by A.G. Rakhmanova. St. Petersburg: SpetsLit, 2016. 379 p. (In Russ.)]
  4. Черноусов А.Ф., Хоробрых Т.В., Карпова Р.В., Зенкова К.И. Регенерация печени при циррозе под действием криопреципитата // Новости хирургии. 2017. Т. 25, № 4. С. 350–358. [Chernousov A.F., Horobryh T.V., Karpova R.V., Zenkova K.I. Regeneration of the liver with cirrhosis under the influence of cryoprecipitate. Novosti Khirurgii = Surgery News, 2017, vol. 25, no. 4, рр. 350–358. (In Russ.)]
  5. Desmet V. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology, 1994, vol. 19, no. 6, pp. 1513–1520. doi: 10.1016/0270-9139(94)90250-x
  6. Huo T.-I., Lee S.-D., Lin H.-C. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int., 2008, vol. 28, no. 5, рр. 606–613.
  7. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., Denk H., Desmet V., Korb G., MacSween R.N., Phillips M., Portmann B.G., Poulsen H., Scheuer P.J., Schmid M., Thaler H. Histological grading and staging of chronic hepatitis. J. Hepatol., 1995, vol. 22, no. 6, pp. 696–699. doi: 10.1016/0168-8278(95)80226-6
  8. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., Kiernan T.W., Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1981 vol. 1, pp. 431–435. doi: 10.1002/hep.1840010511
  9. Lyra A.C., Soares M.B., da Silva L.F., Braga E.L., Oliveira S.A., Fortes M.F., Silva A.G., Brustolim D., Genser B., Dos Santos R.R., Lyra L.G. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur. J. Gastroenterol. Hepatol., 2010, vol. 22, no. 1, рр. 33–42. doi: 10.1097/MEG.0b013e32832eb69a
  10. Schuppan D., Krebs A., Bauer M., Hahn E.G. Hepatitis C and liver fibrosis. Cell Death Differ., 2003, vol. 10, pp. S59–S67. doi: 10.1038/sj.cdd.4401163
  11. Terai S., Takami T., Yamamoto N., Fujisawa K., Ishikawa T., Urata Y., Tanimoto H., Iwamoto T., Mizunaga Y., Matsuda T., Oono T., Marumoto M., Burganova G., Fernando Quintanilha L., Hidaka I., Marumoto Y., Saeki I., Uchida K., Yamasaki T., Tani K., Taura Y., Fujii Y., Nishina H., Okita K., Sakaida I. Status and prospects of liver cirrhosis treatment by using bone marrowderived cells and mesenchymal cells. Tissue Eng. Part B Rev., 2014, vol. 20, no. 3, рр. 206–210. doi: 10.1089/ten.TEB.2013.0527

Supplementary files

There are no supplementary files to display.

Copyright (c) 2021 Vorobeva O.V., Lastochkin A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies